NCT01393795View on ClinicalTrials.gov

Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Pulmonary HypertensionPain

Interventions

DRUG

Qutenza

8% patch

DRUG

Tegaderm

No active drug

Trial Locations (1)

W120HS

Hammersmith Hospital, Imperial College NHS Trust, London

Sponsors

Collaborators (1)

United Therapeutics

All Listed Sponsors

collaborator

United Therapeutics

INDUSTRY

lead

Imperial College London

OTHER

NCT01393795 - Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients | Biotech Hunter | Biotech Hunter